How Angotti was paid
$1.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Other | Total |
|---|---|---|---|---|---|---|
| Vincent J. AngottiChief Executive Officer | $688,811 | $206,643 | $35,563 | $172,260 | $14,000 | $1,117,277 |
| Raffi AsadorianChief Financial Officer | $520,944 | $145,864 | $8,745 | $37,756 | $14,000 | $727,309 |
| Shakil Aslam, M.D.Chief Medical Officer | $473,200 | $121,139 | $8,745 | $37,756 | $14,000 | $654,840 |
What changed and why
- $1.1MChief Executive Officer total compensation increased to $1,117,277 in fiscal 2025 from $1,038,992 in fiscal 2024.
- 3%Base salaries for named executive officers received merit increases of approximately 3% to 4% for 2025.
- Annual cash bonuses were awarded under the 2025 Cash Bonus Plan and paid in the first quarter of 2026.
- Severance arrangements were updated for Raffi Asadorian in July 2025 to increase change in control benefits.
Other Talphera proxy statements
- 2025 proxy statement
Vincent J. Angotti paid $1M (-14% on the year).
Filed Sep 09, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.